Literature DB >> 28154625

African civil society initiatives to drive a biobanking, biosecurity and infrastructure development agenda in the wake of the West African Ebola outbreak.

Akin Abayomi1, Sahr Gevao2, Brian Conton3, Pasquale Deblasio4, Rebecca Katz5.   

Abstract

This paper describes the formation of a civil society consortium, spurred to action by frustration over the Ebola crises, to facilitate the development of infrastructure and frameworks including policy development to support a harmonized, African approach to health crises on the continent. The Global Emerging Pathogens Treatment Consortium, or GET, is an important example of how African academics, scientists, clinicians and civil society have come together to initiate policy research, multilevel advocacy and implementation of initiatives aimed at building African capacity for timely and effective mitigations strategies against emerging infectious and neglected pathogens, with a focus on biobanking and biosecurity. The consortium has been able to establish it self as a leading voice, drawing attention to scientific infrastructure gaps, the importance of cultural sensitivities, and the power of community engagement. The GET consortium demonstrates how civil society can work together, encourage government engagement and strengthen national and regional efforts to build capacity.

Entities:  

Keywords:  Biobanking; biosecurity; consortia; infrastructure

Mesh:

Year:  2016        PMID: 28154625      PMCID: PMC5267819          DOI: 10.11604/pamj.2016.24.270.8429

Source DB:  PubMed          Journal:  Pan Afr Med J


Commentary

Introduction

The 2014-2015 Ebola virus disease outbreak devastated an already weak public health infrastructure in West Africa. Ebola deaths amongst African healthcare workers only exacerbated the problem. The most affected nations had to rely on international response efforts to mitigate the consequences of the disease; a response that came many months too late. It became apparent that a unified, indigenous voice or coalition of African experts to assist with early detection, defining and coordinating the logistics of response on the ground was lacking. This paper describes the formation of a civil society consortium, spurred to action by frustration over the Ebola crises, to facilitate the development of infrastructure and frameworks including policy development to support a harmonized, African approach to health crises on the continent. The Global Emerging Pathogens Treatment Consortium, or GET, is an important example of how African academics, scientists, clinicians and civil society have come together to initiate policy research, multilevel advocacy and implementation of initiatives aimed at building African capacity for timely and effective mitigations strategies against emerging infectious and neglected pathogens. The GET consortium demonstrates how civil society can work together, encourage government engagement and strengthen national and regional efforts to build capacity consistent with the Global Health Security Agenda.

Establishment of GET

The GET consortium was established on the 21st of August 2014 during the peak of the Ebola outbreak and soon after the index case arrived in Lagos, the 23 million population mega city and commercial capital of Nigeria. The consortium's, aim is to bring like-minded and relevant experts together, who are working in Africa to provide indigenous capacity to collectively address an ever increasing menace of emerging and re-emerging dangerous infectious pathogens. As the Ebola outbreak unfolded in Lagos, it became apparent that an unexpected percentage of Ebola patients were surviving. The founding members of GET, amongst other initiatives, prioritized their mission to find an immediate, local solution to counter the spread of Ebola for which there is still no known treatment-particularly in a vulnerable mega city like Lagos. It was hypothesized based on very rudimentary evidence and animal studies, that if the outbreak was not contained, there were going to be an increasing number of survivors and possibly the only immediate solution was the use of passive immunity from survivors using convalescent plasma donations containing anti Ebola antibodies and transfused under stringent conditions to new cases [1, 2]. This approach became a collaborative effort with international partners, aimed at building the regional capacity to harvest, process and submit convalescent plasma to clinical trials during the outbreak. This eventually led to the convalescent trial capacity drive in Liberia, Sierra Leone, Guinea and Nigeria, which is still on going. This was also accompanied by community outreach to survivors as well as developing guidelines and advice on the ethics of research during public health crises. To achieve the objectives of the convalescent approach, the founding GET consortium members reached out to their colleagues across the region, and in particular within Guinea, Sierra Leone and Liberia, to see how this convalescent plasma strategy could be accelerated. The recruitment drive through person to person contact and existing networks of related Africa consortia soon extended across the whole continent with enthusiastic response from professionals from a variety of disciplines offering of their time voluntarily. The network now includes experts from infectious diseases, pathology, bio-informatics, bio-banking, ethics, social science, economics, patient advocacy, logistics, engineers, ecologists, government administrators, creating artist and several other disciplines. A temporary governance structure was developed and officers appointed. The consortium was registered in Nigeria, Ghana and the United States. The GET consortium ultimately intends to register a presence in every African country as well as in major hubs internationally to ensure that the consortium taps into the wider African Diaspora, while also reaching out to international scientists and supporters who have an interest in capacity development on the African Continent. Through initial institutional funding provided by the Bill and Melinda Gates foundation, GET was able to sustain its growth and develop into a fully functional Civil Society Organization aimed at public health policy research and implementation with expanding impact across several sectors of medicine, logistics and the social sciences. Once GET was formally established, the consortium identified a series of priority issues and proposals for immediate action. These priority issues were driven by the fragmented response to the Ebola outbreak, which appeared to lack sensitivity to the cultural and indigenous knowledge based systems of the continent. This resulted in the formation of nine policy and operational working groups (Figure 1). These include: Ethics, Community Engagement, Patient Advocacy, and Support (ECEPAS); Research and Clinical Trials; Plasmapheresis; Grant, Proposal and Publications; Bio-banking, bio-data, bio-safety, biosecurity, bioinformatics (B5); Cultural, Anthropological, Social and Economic Impact (CASE); HIV cure; Climate, Environmental and Disease Surveillance and bio-intelligence (CESI); Media and Communication. Through the executive committee and the working groups, the GET consortium has been able to move rapidly to organized academic partners, governments, international organizations and associated partners.
Figure 1

GET organizational structure

GET organizational structure

Results

In a relatively short period of time, the civil society consortium has been able to forge new partnerships, establish regional positions, and facilitate commitments by governments. Table 1 depicts some of the GET organized events, proposals, and workshops. In collaboration with West African regional partners, GET was instrumental in organizing the first African Voices and Leadership conference on Ebola held in Dakar in January 2015. The meeting brought together representatives from leading regional and continental health authorities (including the United Nations, World Food Programme, World Health Organization, African Union, MSF, ECOWAS, WAHO, NEPAD, and MSF), representatives of the ministries of health of the ECOWAS region, scientists, Ebola survivors and Ebola treatment center health care givers. During this meeting the multitude of socio-economic, infrastructural and capacity deficiencies that permitted the Ebola outbreak to affect so many, were identified and crystalized into what became the Dakar Declaration [3]. This meeting clearly defined key infrastructure deficiencies, such as biobanking facilities and biosecurity infrastructures, and the lack of a framework to address the stigma, rehabilitation and care of Ebola survivors. The necessary policies that would govern such infrastructure development and frameworks required urgent attention. GET has facilitated a series of meetings to explore hosting a conference focused on biobanking and biosecurity infrastructure, and has worked to establish African infrastructure to conduct plasmapheresis and plasma storage facilities in key strategic locations in Africa to support Ebola clinical trials. The success of GET can also be demonstrated in the consortium's interventions in Sierra Leone. GET has provided templates and expertise in fair contract negotiations for clinical trials agreements to ensure intellectual property rights are maintained for the Ebola affected countries. GET also led the drive to ensure the Ebola affected countries were aware of the biosecurity and biosafety threats posed by Ebola samples, given the insecure environments of the current laboratory systems, and provided options to take ownership and control of the samples. The samples left over from the 2014/15 Ebola outbreak were strewn throughout partner labs that were set up all over the subregion. However some of these labs have shut down. More are due to do so, and there is as yet no agreed process regulating safe handing over or disposal of dangerous substances. These remaining samples of Ebola are left without the requisite conventional security to prevent their accidental discharge or intentional theft for unregulated research or possible non-peaceful activities. GET has been entrusted with raising the Government awareness on biobanking, drafting a national policy, and crafting the road map for data rescue of the samples belonging to Sierra Leone with a view to having a safe and sustainable biobank GET used established networks to access the membership of relevant African Societies and established academic research networks such as the H3Africa and B3Africa consortia to build upon established guidelines for sample and data management as the basis for formulating standard operating practices in the Ebola affected countries. These examples illustrate how increased technical expertise, as promoted and shared by GET, enabled south-south collaboration. In addition to these activities organized or supported by GET, the consortium has improved its regional and global recognition as a representative voice committed to improving infrastructure and capacity to cope with public health crises caused by epidemics in Africa. Part of this recognition has been the consistent invitations to participate in and speak at regional, international conferences and policy forums, becoming an important voice in policy discussions around global health security, biosafety, biosecurity, biobanking and ethics. GET is building up a number of reports and manuscripts that document its experience on this trajectory and these can be found on its website [4].
Table 1

GET activities

NameDateOutcome
Ethics, Community Engagement and Ebola Survivor Advocacy and SupportOctober 2014Ethical review of protocol for first ever convalescent trial in Liberia
Lagos State Ministry of HealthOctober 2014Through an MOU with the Lagos State Government Ministry of Health, GET has supported the Ebola Core Research group formed in Lagos
Logistical support for ClinicalRMNovember 2014Logistics for massive air drop of blood mobiles, apheresis machines and medical supplies to Guinea Liberia and Nigeria
Biobanking ProposalJanuary 2015First indigenous initiative proposal for a comprehensive attempt to secure all Ebola samples in the region and develop biobanking and biosafety facilities and frameworks presented to the Global Partnership
First African Voices and Leadership Conference on Ebola and EIDJanuary 2015, SenegalDakar Declaration: Lack of biobanking and biosecurity capacity and frameworks is contributing factor to rapid spread of West African Ebola outbreak
Ebola Survivor Workshop with Ebola Survivors Association of Liberia (ESAL)January 2015, LiberiaGrowth of 500 to 800 survivors registered with ESAL
Ebola Survivor Workshop with Sierra Leone Association of Ebola Survivors (SLAES)February, 2015 Freetown, Sierra Leone.Building network of Ebola survivors and infrastructure. Piloted creative fine art as a means of healing Post Traumatic Stress Disorder experienced by survivors.
Knowledge, Attitude and Perception StudyFebruary 2015, Sierra LeoneIntroduced new study to attempt to understand factors in community that generate discrimination against Ebola survivors.
Engagement with NOGUCHI BSL 3 FacilityAugust 2015, Accra, GhanaDevelopment of Memorandum of Understanding for support to the most affected countries.
1st WHO meeting on Ebola and BiobankingMay 2015, Geneva, SwitzerlandGET represented at first WHO meeting on Ebola and biobanking. Agreed that an accelerated approach to biobanking was required with more indigenous representation to be scheduled in the West African region.
2nd WHO meeting on Ebola survivors and BiobankingAugust 2015 Freetown, Sierra Leone,A continuation of the discussion initiated in Geneva with a more focused approach on indigenous solutions. This was immediately followed by a GET workshop on Biobanking and Biosecurity
National biobanking and biosecurity policy workshop in Sierra LeoneAugust 2015 Freetown, Sierra LeoneFirst indigenous workshop on biobanking and biosecurity, aimed at supporting the Government of Sierra Leone to develop its national biobanking and biosecurity framework.
West African Task force for the research into Emerging and re-emerging Infections (WATER).August 2015Sierra LeoneFounding members of GET and representatives of WATER agreed to synchronize activities in the West African Region, to ensure elimination of duplicity and ensure effective use of resources and human capacity.
MSF-GETAugust 2015 Sierra LeoneSeries of meeting between GET and MSF culminated in a strategic approach to coordinate and support the efforts of GET and WATER to accelerate biobanking and biosecurity capacity in Africa
African GongAugust 2015 Cape Town, South AfricaFounding members of African Gong and GET met to map out the modalities of hosting the first African Conference on Science Communication and Public understanding of science.
WHO Ethics meetingSeptember 2015 Cape Town, South AfricaGET PI gave a summary of the second WHO meeting held in Freetown, aimed at further refining guidelines for the ethical approach to public health emergencies based on lessons learned during the Ebola outbreak.
Trends Symposium to support the Biological Weapons ConventionSeptember 2015 PolandGET Principal Investigator was requested to give an overview of the biosecurity issues in the Ebola affected region and how new technology has made a difference.
Royal College of Pathologists of the United Kingdom (RCPath)September 2015 Kampala, UgandaGET and senior members of the International Division of the Royal College of Pathology, met at the Labskills Africa conference to map out future collaborations
Global Health Security Agenda (GHSA) meeting organized by the African Society of Laboratory Medicine (ASLM).October 2015. Freetown, Sierra Leone.GET members invited, participated in this meeting contributing to improved understanding of the biosecurity deficits in the region.
Africa Union Peace and Security Department. Consultative meeting on the Universalization of the Biological Weapons Convention (BWC) in Africa.October 2015. Addis, EthiopiaGET was invited as a speaker and observer to share experiences in the containment strategies of the Ebola Outbreak and contributions towards capacity building for enhanced implementation of the BWC.
GET activities

Discussion

The GET consortium has been able to establish itself as a leading voice, drawing attention to scientific infrastructure gaps, the importance of cultural sensitivities, and the power of community engagement. These efforts are vital to the core mission of the Global Health Security Agenda-making the world safer from infectious disease threats. The GET consortium is working to build African capacity to detect, respond and recover from infectious diseases, and doing so through their ability to harness the training, passion and capacity of African medical and non-medical professionals. The GET consortium can be a model for all regions of the world, demonstrating that committed civil society can engage in the hardest problems of their region in support of governments and populations. The consortium, however, has faced multiple challenges. Potential research collaborators have questioned the strength of the consortium, and even questioned the possibility of African professionals to desire to come together as they have under GET, complicating fund raising efforts. GET realizes that it should also turn its attention to indigenous funding streams including corporate social responsibility to accelerate the African bio-economy. There are many health related challenges across the African continent due to endemic burden of disease and a multitude of environmental and host factors that facilitate the emergence of biological threats. These health challenges are amplified by an insufficient clinical workforce, infrastructure challenges, strained governments, and limited resources. In the midst of this challenging environment, the GET consortium has emerged as a means for African civil society to work together to support improved health outcomes, strengthen global health security, and build much needed capacity to combat biological threats.
  2 in total

1.  Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

Authors:  John M Dye; Andrew S Herbert; Ana I Kuehne; James F Barth; Majidat A Muhammad; Samantha E Zak; Ramon A Ortiz; Laura I Prugar; William D Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

2.  Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.

Authors:  K Mupapa; M Massamba; K Kibadi; K Kuvula; A Bwaka; M Kipasa; R Colebunders; J J Muyembe-Tamfum
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

  2 in total
  6 in total

Review 1.  Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.

Authors:  Nancy E Cornish; Nancy L Anderson; Diego G Arambula; Matthew J Arduino; Andrew Bryan; Nancy C Burton; Bin Chen; Beverly A Dickson; Judith G Giri; Natasha K Griffith; Michael A Pentella; Reynolds M Salerno; Paramjit Sandhu; James W Snyder; Christopher A Tormey; Elizabeth A Wagar; Elizabeth G Weirich; Sheldon Campbell
Journal:  Clin Microbiol Rev       Date:  2021-06-09       Impact factor: 50.129

2.  How can community engagement in health research be strengthened for infectious disease outbreaks in Sub-Saharan Africa? A scoping review of the literature.

Authors:  Samantha Vanderslott; Manya Van Ryneveld; Mark Marchant; Shelley Lees; Sylvie Kwedi Nolna; Vicki Marsh
Journal:  BMC Public Health       Date:  2021-04-01       Impact factor: 3.295

3.  A framework for the promotion of ethical benefit sharing in health research.

Authors:  Anja Bedeker; Michelle Nichols; Taryn Allie; Tsaone Tamuhla; Peter van Heusden; Olorunyomi Olorunsogbon; Nicki Tiffin
Journal:  BMJ Glob Health       Date:  2022-02

4.  Training Curriculum, Skills, and Competencies for Global Health Leaders: Good Practices and Lessons Learned.

Authors:  Meike J Schleiff; Patrick Mwirigi Mburugu; John Cape; Rama Mwenesi; Nathanael Sirili; Sean Tackett; David P Urassa; Bhakti Hansoti; Yohana Mashalla
Journal:  Ann Glob Health       Date:  2021-07-12       Impact factor: 2.462

5.  REAPing the benefits: development and use of a structured evaluation framework to codify learning resources for Global Health professionals.

Authors:  Meike Schleiff; Elizabeth Hahn; Caroline Dolive; Lillian James; Anant Mishra; Bhakti Hansoti
Journal:  BMC Med Educ       Date:  2021-07-08       Impact factor: 2.463

6.  Rapid establishment of a COVID-19 perinatal biorepository: early lessons from the first 100 women enrolled.

Authors:  Lydia L Shook; Jessica E Shui; Adeline A Boatin; Samantha Devane; Natalie Croul; Lael M Yonker; Juan D Matute; Rosiane S Lima; Muriel Schwinn; Dana Cvrk; Laurel Gardner; Robin Azevedo; Suzanne Stanton; Evan A Bordt; Laura J Yockey; Alessio Fasano; Jonathan Z Li; Xu G Yu; Anjali J Kaimal; Paul H Lerou; Andrea G Edlow
Journal:  BMC Med Res Methodol       Date:  2020-08-26       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.